PMDA drug package insert
モーラステープL40mg
PMDA Prescription drug · 久光製薬株式会社 · package insert Oct 8, 2024
Key facts
| Brand names | モーラステープL40mg |
|---|---|
| Nonproprietary names | ケトプロフェン |
| Companies | 製造販売元／久光製薬株式会社, 発売元／祐徳薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 経皮鎮痛消炎剤 |
| Therapeutic category codes | 872649 |
| YJ codes | 2649729S3084 |
| Approval numbers | 22000AMX00615000 |
| Package insert edition | 第2版 |
| Package insert date | Oct 8, 2024 |
| PMDA document key | 650034_2649729S3084_2 |
| PMDA company code | 650034 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: